2023
In-home Visits and Subsequent Health Outcomes in Medicare Advantage Beneficiaries With Coronary Artery Disease, Diabetes, Hypertension, and Depression
Smolderen K, Heath K, Ameli O, Spencer D, Natwick T, Musich S, Miedico T, Mena-Hurtado C. In-home Visits and Subsequent Health Outcomes in Medicare Advantage Beneficiaries With Coronary Artery Disease, Diabetes, Hypertension, and Depression. Medical Care 2023, 61: 366-376. PMID: 37167558, DOI: 10.1097/mlr.0000000000001850.Peer-Reviewed Original ResearchConceptsPrimary care visitsCoronary artery diseaseMajor adverse cardiovascular eventsFirst primary care visitAdverse cardiovascular eventsCare visitsWait-list control groupHome visitsArtery diseaseList control groupControl groupCardiovascular eventsCare metricsOptum Labs Data WarehouseHigh-morbidity conditionsMedicare Advantage populationInpatient care episodesMedicare Advantage beneficiariesRetrospective data analysisSubsequent health outcomesIndex dateSecondary outcomesEmergency visitsPrimary outcomeInpatient stay
2017
Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient
Patel JP, Lee EH, Mena-Hurtado CI, Walker CN. Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient. Current Cardiology Reports 2017, 19: 89. PMID: 28836189, DOI: 10.1007/s11886-017-0889-z.Peer-Reviewed Original ResearchConceptsErectile dysfunctionHypertensive patientsSexual functionCertain antihypertensive agentsAngiotensin receptor blockersChallenging patient populationFirst-line treatmentDiagnosis of hypertensionCalcium channel blockersTreatment of hypertensionPDE-5 inhibitorsAntihypertensive agentsReviewThe prevalencePatient populationPharmacological treatmentRisk factorsChannel blockersClinical challengeCardiovascular fitnessHypertensionEnzyme inhibitorsPatientsDysfunctionAdverse effectsSexual activity
2014
Renal sympathetic denervation in the treatment of resistant hypertension.
Sánchez-Álvarez C, González-Vélez M, Stilp E, Ward C, Mena-Hurtado C. Renal sympathetic denervation in the treatment of resistant hypertension. The Yale Journal Of Biology And Medicine 2014, 87: 527-35. PMID: 25506285, PMCID: PMC4257026.Peer-Reviewed Original ResearchConceptsTreatment-resistant hypertensionRenal sympathetic denervationSympathetic denervationBlood pressureRenal arteryEfficacy of RSDSYMPLICITY HTN-3 studyDifferent antihypertensive medicationsSympathetic nerve hyperactivityMinor adverse eventsTarget blood pressureCommon femoral arteryMain renal arteryMajor health problemAntihypertensive medicationsRenal denervationRenal sympathectomySymplicity catheterArterial hypertensionResistant hypertensionAdverse eventsConsiderable morbidityEndovascular approachFemoral arteryConcomitant useDysautonomic responses during percutaneous carotid intervention
Bujak M, Stilp E, Meller SM, Cal N, Litsky J, Setaro JF, Mena C. Dysautonomic responses during percutaneous carotid intervention. Catheterization And Cardiovascular Interventions 2014, 85: 282-291. PMID: 25131191, DOI: 10.1002/ccd.25622.Peer-Reviewed Original ResearchConceptsCarotid artery stentingPercutaneous carotid artery stentingPostganglionic sympathetic nerve activityNeuro-vascular complicationsSympathetic nerve activityLong-term outcomesCarotid atherosclerotic diseaseLong-term safetyAutonomic dysfunctionBaroreceptor stimulationPeriprocedural managementPeriprocedural periodArtery stentingNerve activityAtherosclerotic diseaseCarotid endarterectomyPrognostic significanceRetrospective studyCarotid sinusRisk factorsBalloon inflationInvasive alternativeProcedural experienceConsistent findingHomeostasis results